Ketankumar Patel (Ketan Patel)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 32

Top Topics

Escherichia Coli

Top Venues

Nanomedicine (London, England)

Current issues in molecular biology

This page only lists publications with an associated author ORCID identifier.

Publications

Shraddha Bhutkar, Anjali Yadav, Himaxi Patel, Shrikant Barot, Ketankumar Patel, Vikas V Dukhande
Synergistic Efficacy of CDK4/6 Inhibitor Abemaciclib and HDAC Inhibitor Panobinostat in Pancreatic Cancer Cells. Cancers 16 (15) (2024)
Shraddha Bhutkar, Anjali Yadav, Himaxi Patel, Shrikant Barot, Ketankumar Patel, Vikas V Dukhande
Synergistic Efficacy of CDK4/6 Inhibitor Abemaciclib and HDAC Inhibitor Panobinostat in Pancreatic Cancer Cells. Cancers 16 (15) (2024)
Shraddha Bhutkar, Anjali Yadav, Himaxi Patel, Shrikant Barot, Ketankumar Patel, Vikas V Dukhande
Synergistic Efficacy of CDK4/6 Inhibitor Abemaciclib and HDAC Inhibitor Panobinostat in Pancreatic Cancer Cells. Cancers 16 (15) (2024)
Xiuyi Liang, Agata J Pacuła-Miszewska, Richa Vartak, Milankumar Prajapati, Haiyan Zheng, Caifeng Zhao, Ganming Mao, Ketankumar Patel, Natalya U Fedosova, Jacek Ścianowski, Blase Billack
N -3-Methylbutyl-benzisoselenazol-3(2H)-one Exerts Antifungal Activity In Vitro and in a Mouse Model of Vulvovaginal Candidiasis. Current issues in molecular biology 46 (3) (2024)
Xiuyi Liang, Agata J Pacuła-Miszewska, Richa Vartak, Milankumar Prajapati, Haiyan Zheng, Caifeng Zhao, Ganming Mao, Ketankumar Patel, Natalya U Fedosova, Jacek Ścianowski, Blase Billack
N -3-Methylbutyl-benzisoselenazol-3(2H)-one Exerts Antifungal Activity In Vitro and in a Mouse Model of Vulvovaginal Candidiasis. Current issues in molecular biology 46 (3) (2024)
Xiuyi Liang, Agata J Pacuła-Miszewska, Richa Vartak, Milankumar Prajapati, Haiyan Zheng, Caifeng Zhao, Ganming Mao, Ketankumar Patel, Natalya U Fedosova, Jacek Ścianowski, Blase Billack
N -3-Methylbutyl-benzisoselenazol-3(2H)-one Exerts Antifungal Activity In Vitro and in a Mouse Model of Vulvovaginal Candidiasis. Current issues in molecular biology 46 (3) (2024)
Xiuyi Liang, Agata J Pacuła-Miszewska, Richa Vartak, Milankumar Prajapati, Haiyan Zheng, Caifeng Zhao, Ganming Mao, Ketankumar Patel, Natalya U Fedosova, Jacek Ścianowski, Blase Billack
N -3-Methylbutyl-benzisoselenazol-3(2H)-one Exerts Antifungal Activity In Vitro and in a Mouse Model of Vulvovaginal Candidiasis. Current issues in molecular biology 46 (3) (2024)
Aishwarya Saraswat, Ketankumar Patel
Delineating effect of headgroup and preparation method on transfection versus toxicity of DNA-loaded lipid nanocarriers. Nanomedicine (London, England) (2023)
Terjahna Richards, Himaxi Patel, Ketankumar Patel, Frank Schanne
Endogenous Lipid Carriers-Bench-to-Bedside Roadblocks in Production and Drug Loading of Exosomes. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Xiuyi Liang, Agata J Pacuła-Miszewska, Magdalena Obieziurska-Fabisiak, Richa Vartak, Ganming Mao, Ketankumar Patel, Natalya U Fedosova, Jacek Ścianowski, Blase Billack
Selected N -Terpenyl Organoselenium Compounds Possess Antimycotic Activity In Vitro and in a Mouse Model of Vulvovaginal Candidiasis. Molecules (Basel, Switzerland) 28 (21) (2023)
Snehal Daware, Vishvesh Raje, Akanksha Patel, Ketankumar Patel
Investigating Key Molecular Descriptors Affecting Particle Size: A Predictive Exemplary Approach for Self-Emulsifying System. Molecular pharmaceutics (2023)
Atanu Das, Richa Vartak, Md Asrarul Islam, Sunil Kumar, Jun Shao, Ketankumar Patel
Arginine-Coated Nanoglobules for the Nasal Delivery of Insulin. Pharmaceutics 15 (2) (2023)
Poonam Gawali, Aishwarya Saraswat, Shruti Bhide, Sanjay Gupta, Ketankumar Patel
Human solid tumors and clinical relevance of the enhanced permeation and retention effect: a 'golden gate' for nanomedicine in preclinical studies? Nanomedicine (London, England) (2023)
Sabrina Banella, Aishwarya Saraswat, Akanksha Patel, Abu T M Serajuddin, Paolo Colombo, Ketankumar Patel, Gaia Colombo
In Vitro Assessment of Cisplatin/Hyaluronan Complex for Loco-Regional Chemotherapy. International journal of molecular sciences 24 (21) (2023)
Terjahna Richards, Himaxi Patel, Ketankumar Patel, Frank Schanne
Endogenous Lipid Carriers-Bench-to-Bedside Roadblocks in Production and Drug Loading of Exosomes. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Atanu Das, Richa Vartak, Md Asrarul Islam, Sunil Kumar, Jun Shao, Ketankumar Patel
Arginine-Coated Nanoglobules for the Nasal Delivery of Insulin. Pharmaceutics 15 (2) (2023)
Atanu Das, Richa Vartak, Md Asrarul Islam, Sunil Kumar, Jun Shao, Ketankumar Patel
Arginine-Coated Nanoglobules for the Nasal Delivery of Insulin. Pharmaceutics 15 (2) (2023)
Terjahna Richards, Himaxi Patel, Ketankumar Patel, Frank Schanne
Endogenous Lipid Carriers-Bench-to-Bedside Roadblocks in Production and Drug Loading of Exosomes. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Xiuyi Liang, Suvidha Menon, Richa Vartak, Radosław Gaida, Elżbieta Wojaczyńska, Ketankumar Patel, Blase Billack
Nanoformulation of a novel potent ebselen analog for treatment of vulvovaginal candidiasis. Nanomedicine (London, England) (2023)
Atanu Das, Richa Vartak, Md Asrarul Islam, Sunil Kumar, Jun Shao, Ketankumar Patel
Arginine-Coated Nanoglobules for the Nasal Delivery of Insulin. Pharmaceutics 15 (2) (2023)
Vishvesh Raje, Siddhant Palekar, Sabrina Banella, Ketankumar Patel
Tunable Drug Release from Fused Deposition Modelling (FDM) 3D-Printed Tablets Fabricated Using a Novel Extrudable Polymer. Pharmaceutics 14 (10) (2022)
Akanksha Patel, Aishwarya Saraswat, Harsh Patel, Zhe-Sheng Chen, Ketankumar Patel
Palmitoyl Carnitine-Anchored Nanoliposomes for Neovasculature-Specific Delivery of Gemcitabine Elaidate to Treat Pancreatic Cancer. Cancers 15 (1) (2022)
Akanksha Patel, Aishwarya Saraswat, Harsh Patel, Zhe-Sheng Chen, Ketankumar Patel
Palmitoyl Carnitine-Anchored Nanoliposomes for Neovasculature-Specific Delivery of Gemcitabine Elaidate to Treat Pancreatic Cancer. Cancers 15 (1) (2022)
Asad Mir, Richa V Vartak, Ketankumar Patel, Steven M Yellon, Sandra E Reznik
Vaginal Nanoformulations for the Management of Preterm Birth. Pharmaceutics 14 (10) (2022)
Akanksha Patel, Aishwarya Saraswat, Harsh Patel, Zhe-Sheng Chen, Ketankumar Patel
Palmitoyl Carnitine-Anchored Nanoliposomes for Neovasculature-Specific Delivery of Gemcitabine Elaidate to Treat Pancreatic Cancer. Cancers 15 (1) (2022)
Yige Fu, Aishwarya Saraswat, Zenghui Wei, Manas Yogendra Agrawal, Vikas V Dukhande, Sandra E Reznik, Ketankumar Patel
Development of Dual ARV-825 and Nintedanib-Loaded PEGylated Nano-Liposomes for Synergistic Efficacy in Vemurafnib-Resistant Melanoma. Pharmaceutics 13 (7) (2021)
Richa Vartak, Suyash M Patil, Aishwarya Saraswat, Manali Patki, Nitesh K Kunda, Ketankumar Patel
Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro. Nanomedicine (London, England) 16 (14) (2021)
Aishwarya Saraswat, Richa Vartak, Manali Patki, Ketankumar Patel
Cannabidiol Inhibits In Vitro Human Liver Microsomal Metabolism of Remdesivir: A Promising Adjuvant for COVID-19 Treatment. Cannabis and cannabinoid research (2021)
Aishwarya Saraswat, Manali Patki, Yige Fu, Shrikant Barot, Vikas V Dukhande, Ketankumar Patel
Nanoformulation of PROteolysis TArgeting Chimera targeting 'undruggable' c-Myc for the treatment of pancreatic cancer. Nanomedicine (London, England) 15 (18) (2020)
Manali Patki, Kiersten Giusto, Samir Gorasiya, Sandra E Reznik, Ketankumar Patel
17-α Hydroxyprogesterone Nanoemulsifying Preconcentrate-Loaded Vaginal Tablet: A Novel Non-Invasive Approach for the Prevention of Preterm Birth. Pharmaceutics 11 (7) (2019)
Tasneem Gandhi, Manali Patki, Jing Kong, Jagadish Koya, Sabesan Yoganathan, Sandra Reznik, Ketankumar Patel
Development of an Arginine Anchored Nanoglobule with Retrograde Trafficking Inhibitor (Retro-2) for the Treatment of an Enterohemorrhagic Escherichia coli Outbreak. Molecular pharmaceutics 16 (10) (2019)
Yige Fu, Drishti Rathod, Ehab M Abo-Ali, Vikas V Dukhande, Ketankumar Patel
EphA2-Receptor Targeted PEGylated Nanoliposomes for the Treatment of BRAFV600E Mutated Parent- and Vemurafenib-Resistant Melanoma. Pharmaceutics 11 (10) (2019)